1. Home
  2. MDA vs ABCL Comparison

MDA vs ABCL Comparison

Compare MDA & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MDA Space Ltd. Common Shares

MDA

MDA Space Ltd. Common Shares

N/A

Current Price

$29.04

Market Cap

4.2B

ML Signal

N/A

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

N/A

Current Price

$11.58

Market Cap

4.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MDA
ABCL
Founded
1969
2012
Country
Canada
Canada
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
4.1B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
MDA
ABCL
Price
$29.04
$11.58
Analyst Decision
Buy
Strong Buy
Analyst Count
14
13
Target Price
★ $41.80
$18.00
AVG Volume (30 Days)
753.7K
★ 3.2M
Earning Date
11-05-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 10.91
EPS
★ N/A
N/A
Revenue
N/A
★ $75,128,000.00
Revenue This Year
$18.41
N/A
Revenue Next Year
$47.69
$10.03
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 160.56
52 Week Low
$23.23
$2.75
52 Week High
$49.37
$14.98

Technical Indicators

Market Signals
Indicator
MDA
ABCL
Relative Strength Index (RSI) 50.18 45.51
Support Level $28.44 $10.65
Resistance Level $29.76 $13.21
Average True Range (ATR) 1.60 1.00
MACD 0.26 -0.06
Stochastic Oscillator 53.75 25.16

Price Performance

Historical Comparison
MDA
ABCL

About MDA MDA Space Ltd. Common Shares

MDA Space Ltd is a developer and manufacturer of technology and services to the space industry. It is an international space mission partner and robotics, satellite systems, and geo-intelligence pioneer. It is engaged in communications satellites, Earth and space observation, space exploration, and infrastructure. The Company collaborates and partners with governments and space agencies, commercial space companies, and defence and aerospace prime contractors in the space industry. Geographically, it generates the majority of its revenue from Canada.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: